Trial Profile

A phase Ia/Ib clinical trial of MRG 003 in advanced recurrent squamous cell carcinoma of the Head and Neck

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 05 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MRG 003 (Primary)
Indications Head and neck cancer; Squamous cell cancer
Focus Adverse reactions
Sponsors Lepu Biopharma

Most Recent Events

05 Apr 2022 New trial record
21 Nov 2021 According to Lepu Biopharma media release, the company expects to initiate phase Ia/Ib clinical trials in recurrent or metastatic advanced HNSCC in the U.S.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com